You are here: Home > Institute of Excellence (CPD) > CPD Events > PHARMA – September 2019

PHARMA - September 2019

Available from: 1/09/2019


Provider: OA National Provider


Learning Objectives

  • Become more familiar with the therapeutic medication management of myopia progression via the use of low dose atropine
  • Become more familiar with the various paediatric optic nerve anomalies that may be encountered in clinical practice
  • Gain an understanding of the ease of access and barriers that parents need to overcome in the eye care provision of young children
  • Become more familiar with the clinical management guidelines for myopia and where therapeutic medication management fits within the model
  • Gain an understanding of the prevalence of myopia in school aged children
  • Become more familiar with the epidemiological data relating to myopia and how/why optometrists can/should implement myopia control strategies for their patients
  • Become more familiar with daily disposable multifocal soft contact lenses as a method of myopia control
  • Become more familiar with orthokeratology contact lenses as a method of myopia control
  • Become more familiar with digital eye strain, how digital devices may impact people & their sleep patterns and how to manage patients with this condition
  • Gain an understanding of how accommodative-vergence dysfunction can contribute to learning difficulties in children

Max points awarded: 6.00

Session Information

Name
PHARMA - September 2019
Activity Type
Independent Learning with Assessment
Therapeutic?
Yes
Manufacturer/Supplier?
No
Points for attending & Passing Assessment
1.00
Name
PHARMA - September 2019
Activity Type
Independent Learning with Assessment
Therapeutic?
No
Manufacturer/Supplier?
No
Points for attending & Passing Assessment
5.00

Acknowledgement of Country

In the spirit of reconciliation Optometry Australia acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their Elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.